tolvaptan has been researched along with valproic acid in 2 studies
| Studies (tolvaptan) | Trials (tolvaptan) | Recent Studies (post-2010) (tolvaptan) | Studies (valproic acid) | Trials (valproic acid) | Recent Studies (post-2010) (valproic acid) |
|---|---|---|---|---|---|
| 967 | 172 | 786 | 14,155 | 1,256 | 5,108 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Burtey, S | 1 |
2 review(s) available for tolvaptan and valproic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Slow the pace of renal failure in autosomal dominant polycystic kidney disease: hopes and disappointments].
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Chromosomes, Human, Pair 16; Clinical Trials as Topic; Comorbidity; Cyclic AMP; DNA Mutational Analysis; Drugs, Investigational; Genetic Carrier Screening; Histone Deacetylases; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Function Tests; Metformin; Mice; Polycystic Kidney, Autosomal Dominant; Prognosis; Rats; Signal Transduction; Somatostatin; Tolvaptan; TOR Serine-Threonine Kinases; TRPP Cation Channels; Valproic Acid | 2011 |